30 Years of Evidence
Featured Content
pancreatic cancer awareness
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
pancreatic cancer awareness
Long-Term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-Metastatic Pancreatic Cancer
pancreatic cancer awareness
Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer
Time-resolved Biological Effective Dose Distributions in Stereotactic Radiosurgery for Vestibular Schwannomas: A Comparative Analysis Between Two Dedicated Stereotactic Radiosurgery Systems
Moutsatsos A, Cotrutz C, Stergioula A, Tuleasca C, Pantelis E | Phys Med Biol | 2025
Long-term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-metastatic Pancreatic Cancer
Cao BY, Zhang LT, Wu CC, Wang J | Radiother Oncol. | 2025
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
Zhang Z, Tian B, Xu H, Huang H, Liang X, Bo C, Bian Y, Wei M, Zhao Z | Cancer Manag Res | 2025
Stereotactic Reirradiation with CyberKnife for Locally Recurrent Prostate Cancer, Long-term Toxicity and Clinical Outcomes from a Monocentric Cohort
Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Becherini C, Visani L, Salvestrini V, Simontacchi G, Greto D, Bonomo P, Doro R, Masi L, Desideri I, Meattini I, Serni S, Livi L | Radiol Med | 2023
Intensity Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: Five-year Outcomes
Carrasquilla M, Sholklapper T, Pepin AN, Hodgins N, Lei S, Rashid A, Danner M, Zwart A, Bolanos G, Ayoob M, Yung T, Aghdam N, Collins B, Suy S, Kumar D, Hankins R, Kowalczyk K, Dawson N, Collins S | Front Oncol | 2023
Accuracy of Robotic Radiosurgery in Renal Cell Carcinoma
Hofmann T, Kohlhase N, Eftimova D, Eder MM, Staehler M, Ruge MI, Muacevic A, Fürweger C | Phys Med | 2024
Revisiting Radioresistance: A Systematic Review of Outcomes of Stereotactic Radiosurgery (SRS) in Functional Head and Neck Paragangliomas
Verma O, Mantziaris G, Das L, Sheehan JP, Tripathi M | Neurosurg Rev. | 2025
Hypofractionated Radiosurgery (25 Gy/5 fractions) for Optic Nerve Sheath Meningiomas: Results from an Exploratory Phase 2 Prospective Trial
Fariselli L, Marzoli SB, Morlino S, Pinzi V, Pedone C, De Martin E, Romeo A, Tramacere I, Marchetti M | Int J Radiat Oncol Biol Phys. | 2025
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
Park DJ, Lee I, Annagiri S, Chou KN, Zamarud A, Akhavan-Sigari A, Hori YS, Persad AR, Abu-Reesh D, Lam FC, Tayag A, Ustrzynski L, Emrich SC, Gu X, Pollom EL, Chang SD | Neurosurgery. | 2025
Computed Tomography Guided Online Adaptive Stereotactic Body Radiation Therapy for Lymph Node Oligometastases: Impact on Dose to Target and Organs at Risk
van Werkhoven LA, Milder MTW, Schillemans W, Hoogeman MS, Nout RA, Nuyttens JJ | Int J Radiat Oncol Biol Phys. | 2025
Pattern of Recurrence After Fractionated Stereotactic Reirradiation in Adult Glioblastoma
Margulies A, Sahki N, Rech F, Vogin G, Blonski M, Peiffert D, Taillandier L, Lesanne G, Demogeot N | Radiat Oncol. | 2025
Low-Burden Oligometastatic Disease of the Lung Treated with Robotic Stereotactic Ablative Radiotherapy: A Retrospective Study
Zygogianni A, Koukourakis IM, Liakouli Z, Desse D, Georgakopoulos I, Armpilia C, Lymperopoulou G, Kouloulias V | Biomedicines. | 2025
Risk-adapted Stereotactic Body Radiation Therapy for the Treatment of Large (>3 cm) Primary Lung Cancer with or without Histologic Confirmation: A Propensity Score Matched and Weighted Analysis
Zeng HY, Li YJ, Ji CZ, Wang HH, Yu XR, He Y, Bai H, Zheng BY, Yan YY, Xu JW, Zaorsky NG, Shi JM, Dong Y, Yu XY, Wang JS, Song YC, Yuan ZY, Chen Y, Meng MB. | Radiother Oncol. | 2025
Local Control and Recurrence Patterns after Stereotactic Irradiation Delivered in more than 4 Fractions for Hepatocellular Carcinomas and liver metastases: a retrospective study
Renan A, Bruand M, Jolnerovski M, Diallo A, Demogeot N | Radiat Oncol. | 2025
Time-resolved Biological Effective Dose Distributions in Stereotactic Radiosurgery for Vestibular Schwannomas: A Comparative Analysis Between Two Dedicated Stereotactic Radiosurgery Systems
Moutsatsos A, Cotrutz C, Stergioula A, Tuleasca C, Pantelis E | Phys Med Biol | 2025
Long-term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-metastatic Pancreatic Cancer
Cao BY, Zhang LT, Wu CC, Wang J | Radiother Oncol. | 2025
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
Zhang Z, Tian B, Xu H, Huang H, Liang X, Bo C, Bian Y, Wei M, Zhao Z | Cancer Manag Res | 2025
Performance Evaluation of SGRT Technology in Conjunction with a Helical Delivery Platform for DIBH in Left-Sided Breast Cancer Treatment
Amit Nirhali et al. | ASTRO | 2025
Obliteration with Preservation: Functional MRI as a Critical Adjunct in Optimizing Radiosurgical Outcomes for Eloquent AVMs
Vangipuram Shankar et al. | ASTRO | 2025
Five-Year Outcomes of Robotic Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer
Tal Sherman et al. | ASTRO | 2025
Evaluation of New SGRT-Based Approach to DIBH for Left-Sided Breast Cancers on a Helical Delivery Platform
Sanjay Hunugundmath et al. | ASTRO | 2025